top of page
![](https://static.wixstatic.com/media/81556e_8285ba1dff5e400a8c7aaf805e15b62b~mv2.jpg/v1/fill/w_924,h_300,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/81556e_8285ba1dff5e400a8c7aaf805e15b62b~mv2.jpg)
Treatment
Once a diagnosis of prostate cancer has been made a decision needs to be made for the steps to take next for management and treatment. The decision will depend on a number of factors including:
-
Gleason score – high (more aggressive), intermediate (Gleason 7), or low grade
-
stage of the cancer – localised in the prostate gland or spread to other parts of the body
-
level of PSA in the blood and the rate of change of PSA over time (velocity)
-
age and general health
-
side-effects of treatment
-
personal preference.
To help with making decisions about treatment, patients can be placed into high, intermediate or low risk groups with respect to likely cancer outcome. This is done using a combination of factors.
![prostate surgeon, prostate cancer, bph, urolift, holep, rezum](https://static.wixstatic.com/media/81556e_ac1c29958b0c47b19e91c6b67469a81f~mv2_d_2800_1867_s_2.jpg/v1/fill/w_379,h_240,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/81556e_ac1c29958b0c47b19e91c6b67469a81f~mv2_d_2800_1867_s_2.jpg)
bottom of page